Publications by authors named "Mylan Blomquist"

Claim this Profile
G
Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppression.
Mylan R Blomquist, Teresa M R Noviello, Christopher Sereduk, Dustin Grief, Francesca P Caruso

J Transl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of delayed diagnosis of disseminated coccidioidomycosis highlights opportunities for improved awareness.
Mylan Blomquist, Jacob Karsten, Brandon Larsen, Erin Graf

ASM Case Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma.
Mylan R Blomquist, Ryan Eghlimi, Angad Beniwal, Dustin Grief, David G Nascari

Int J Mol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures.
Leland S Hu, Fulvio D'Angelo, Taylor M Weiskittel, Francesca P Caruso, Shannon P Fortin Ensign, Mylan R Blomquist

Nat Commun· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression.
Mylan R Blomquist, Shannon Fortin Ensign, Fulvio D'Angelo, Joanna J Phillips, Michele Ceccarelli

Neurooncol Adv· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma.
Bryan G Harder, Mylan R Blomquist, Junwen Wang, Anthony J Kim, Graeme F Woodworth

Front Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis